MDC Afternoon for Immunology
We are excited to announce the next session of our MDC Afternoons for Immunology, a quarterly event aimed at bringing together scientists across diverse immunological backgrounds, enhancing networking, and strengthening connections across the Max Delbrück Center and Berlin.
Keynote
This time, we have a fantastic keynote speaker: Novalia Pishesha
Novalia Pishesha is an Assistant Professor of Pediatrics at Harvard Medical School and Boston Children’s Hospital, where her lab studies antigen processing and presentation and how to manipulate them to modulate immunity. Its core tools are camelid-derived nanobodies (single-domain antibodies). To suppress pathogenic immunity, modified nanobodies deliver anti-inflammatory cues with controlled timing and location, aiming for durable, antigen-specific tolerance in autoimmune and allergic disease. The group tests these approaches in preclinical models of multiple sclerosis, type 1 diabetes, rheumatoid arthritis, lupus and asthma. In the opposite direction, the lab develops nanobody approaches to strengthen immune responses in influenza, malaria and cancer. It also uses nanobody-based immuno-PET to visualize antigen-specific immune responses in vivo without invasive procedures. Pishesha trained in bioengineering at UC Berkeley and earned her PhD in biological engineering at MIT under Harvey Lodish and Hidde Ploegh. She then held a Junior Fellowship at the Harvard Society of Fellows, with mentorship from Aviv Regev (Broad Institute) and Sangeeta Bhatia (Koch Institute). She launched her independent lab at Boston Children’s Hospital in January 2024, and her program has been supported by awards including the National Multiple Sclerosis Society Career Transition Award, the Breakthrough T1D Career Development Award and a Lupus Research Alliance Innovative Award."
- Program
14:10-14:30
Klara Penkert
Leif Ludwig lab
Max Delbrück Center for Molecular Medicine - BIHGut feeling: the colonic cellular landscape during health and IBD
14:30-14:50
Johannes Holler
Johannes Huppa lab
Charité – Universitätsmedizin BerlinOn the role of TCR cross-reactivity towards self-antigens in the defense against cancer
14:50-15:10
Anna-Lena Spierling
Uta Höpken lab
Max Delbrück Center for Molecular MedicineDevelopment of next-generation CAR-T cells targeting both neuroblastoma and the tumor-supportive microenvironment in bone marrow metastases
15:10-15:30
Yu-Hsin Hsieh
Leif Ludwig lab
Max Delbrück Center for Molecular Medicine - BIHTBD
15:30-16:00
Coffee break
16:00-17:00
Novalia Pishesha
Boston Children's Hospital & Harvard Medical School
Engineered Nanobodies to Direct and Visualize Immune Tolerance17:00
Social mixer…great opportunity to network!
Venue
MDC-BIMSB
Robert-Rössle-Straße 10
10115 Berlin
Deutschland
Zeit
Organisator*innen
Organizing Committee (listed alphabetically):
Marc Lucas Appis, Sebastian Hofer, Alisa Iakupova, Tzu-Jiun Kuo, Maria Teresa Norcia, Nataša Puzović and Simon Rapp
Advisory Committee:
Johannes Huppa, Simon Haas